IL6 and lung carcinoma: We found that the effect of IL‐6 promoting EMT of lung cancer cells was weakened in TIM‐4 shRNA group, and TIM‐4 knockdown significantly reversed IL‐6‐induced migratory ability and invasive activity in vitro.